A new study led by researchers at Oxford Population Health shows that higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of ...
The prospective, multicenter, randomized phase 2 ZZ-FIRST clinical trial, led by the Vall d'Hebron Institute of Oncology's ...
Dakar ‒ Prostate cancer is one of the most common male cancers on the African continent. Studies report high incidence and mortality rates among African men compared to men of other origins. This is ...
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the ArteraAI Prostate Test (Post-RP) has been included in the ...
Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...
Prostate cancer is the most commonly diagnosed invasive cancer among South African men, yet it can develop without obvious ...
NCCN guidelines now list the ArteraAI Prostate Test for risk stratification in patients with biochemical recurrence after radical prostatectomy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results